Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

GLEN D VANDERSCHAAF

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1225596968
CMS profile
11124989
Location
GRAND RAPIDS, MI

General Payments · PY2021

$307.36

  • Reported across 19 records
  • CMS publication 2026-06-30

Latest program year · PY2021

$307.36

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $307.36 19

By paying entity

PY2021 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $307.36 19

Payment records · PY2021 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2021
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AbbVie Inc. $19.61 02/10/2021 Food and Beverage Undisputed 06/30/2026 795817861 CMS
AbbVie Inc. $15.38 02/27/2021 Food and Beverage Undisputed 06/30/2026 795817865 CMS
AbbVie Inc. $15.99 05/12/2021 Food and Beverage Undisputed 06/30/2026 795817869 CMS
AbbVie Inc. $12.70 06/04/2021 Food and Beverage Undisputed 06/30/2026 795817873 CMS
AstraZeneca Pharmaceuticals LP $14.72 01/15/2021 Food and Beverage Undisputed 06/30/2026 829543129 CMS
AstraZeneca Pharmaceuticals LP $13.26 03/26/2021 Food and Beverage Undisputed 06/30/2026 829561255 CMS
AstraZeneca Pharmaceuticals LP $13.81 05/05/2021 Food and Beverage Undisputed 06/30/2026 829544611 CMS
AstraZeneca Pharmaceuticals LP $18.15 05/21/2021 Food and Beverage Undisputed 06/30/2026 830096793 CMS
Lilly USA, LLC $16.06 01/08/2021 Food and Beverage Undisputed 06/30/2026 819236991 CMS
Lilly USA, LLC $14.66 01/15/2021 Food and Beverage Undisputed 06/30/2026 818874733 CMS
Lilly USA, LLC $17.18 02/16/2021 Food and Beverage Undisputed 06/30/2026 818877887 CMS
Lilly USA, LLC $15.66 04/02/2021 Food and Beverage Undisputed 06/30/2026 818877885 CMS
Neurelis, Inc. $14.53 04/21/2021 Food and Beverage Undisputed 06/30/2026 842895585 CMS
Novo Nordisk Inc $11.25 02/12/2021 Food and Beverage Undisputed 06/30/2026 810916193 CMS
Novo Nordisk Inc $18.37 04/09/2021 Food and Beverage Undisputed 06/30/2026 810783037 CMS
PFIZER INC. $19.60 01/22/2021 Food and Beverage Undisputed 06/30/2026 833520077 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.47 04/14/2021 Food and Beverage Undisputed 06/30/2026 850290843 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.16 02/24/2021 Food and Beverage Undisputed 06/30/2026 820678707 CMS
Teva Pharmaceuticals USA, Inc. $19.80 03/31/2021 Food and Beverage Undisputed 06/30/2026 839603513 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021
Source files
Dataset page · Bulk file · PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.